Sponsors
Caribou Biosciences Inc
Caribou Biosciences is a clinical-stage CRISPR genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company’s genome-editing platform, including its Cas12a chRDNA technology, enables superior precision to develop cell therapies that are armored to potentially improve activity against diseases. Caribou is advancing a pipeline of off-the-shelf cell therapies from its CAR-T cell platform as readily available treatments for patients with hematologic malignancies and autoimmune diseases.
Gilead
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.
Based in Melbourne, Gilead Sciences Australia and New Zealand employs over 100 people.
AbbVie
AbbVie’s mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. Through a targeted, patient-centric approach to research and development, AbbVie accelerates new scientific discoveries to address some of the most complex diseases in the world, and advocates to enable greater access to innovative medicines, driving outcomes for the health of all Australians. AbbVie is committed to tackling the toughest, most difficult-to-treat cancers in the world with high unmet needs.
Mallinckrodt
Mallinckrodt is a global business consisting of multiple wholly owned subsidiaries that develops, manufactures, markets and distributes specialty pharmaceutical products and therapies. Therakos® is a specialty brand of Mallinckrodt that focuses on the delivery of Extracorporeal Photopheresis (ECP) Immunomodulation. The THERAKOS® CELLEX® Photopheresis System is the world’s only fully integrated closed ECP system and is used by over 300 treatment centres in over 30 countries worldwide. To learn more about this product, visit our website and refer to the full Product Information before prescribing therakos.com.au.
Jazz Pharmaceuticals
Jazz Pharmaceuticals is a global Biopharmaceutical Company whose purpose is to transform the lives of patients and their families through innovation. We are dedicated to developing life-changing medicines for people with serious diseases—often with limited or no therapeutic options so they can live their lives more fully.
We have a diverse portfolio of marketed medicines and novel product candidates, from early- to late-stage development, in Neuroscience and Haematology/Oncology. Within these therapeutic areas, we are identifying new options for patients by actively exploring small molecules and biologics, and through innovative delivery technologies and cannabinoid science.
Jazz Pharmaceuticals has employees around the globe including Australia and New Zealand, serving patients in nearly 75 countries.
